PDE4A and chronic bronchitis: These patients have limited additional add-on treatment options: GOLD suggests azithromycin treatment for former smokers or the oral PDE4 inhibitor roflumilast in patients with a chronic bronchitis phenotype and with forced expiratory volume in 1 s (FEV1) lower than 50% of their predicted value (GOLD, 2021).